Julia HawkinsinLocalGlobe NotesOur investment in Spore.BioThis post was originally published on LinkedIn, November 2023.Sep 13Sep 13
Julia HawkinsinLocalGlobe NotesOur investment in Early: making the invisible detectableWe are at the start of a massive healthcare wave, which will see the emphasis move from sick care to health care.Sep 25, 2023Sep 25, 2023
Julia HawkinsinLocalGlobe NotesOur investment in NoalaWe’re so excited to be backing Emilie Spire and Noala building a community & content SaaS-enabled marketplace for Speech Therapy.Oct 20, 2022Oct 20, 2022
Julia HawkinsinLocalGlobe NotesDecentralised Science — a cure for the Science sector’s woes?Sep 27, 20223Sep 27, 20223
Julia HawkinsinLocalGlobe NotesYulife: from beach to hillsideHuge congrats to YuLife on raising $120M Series C, led by leading insurance company Dai-Ichi Life.Jul 8, 2022Jul 8, 2022
Julia HawkinsinLocalGlobe NotesOur investment in Get HenryWe’re delighted to be leading Get Henry’s seed, building the picks and shovels of last mile delivery: from providing e-delivery vehicles…May 11, 2022May 11, 2022
Julia HawkinsinLocalGlobe NotesOur investment in ArKArK is building a data driven lending business for the next economy. Our core belief is that the next Fortune 500 companies will need to…Mar 29, 2022Mar 29, 2022
Julia HawkinsinLatitude NotesHuge congratulations to Oxford Nanopore as it makes its’ debut on LSE today.Oxford Nanopore is a UK science & technology success story — in many ways it’s a case study in going from the lab to a listing and seeing…Oct 1, 20211Oct 1, 20211
Julia HawkinsinLocalGlobe NotesOur investment in ViraWe’re very proud to announce our investment in Vira Health, a London based startup bringing us personalized menopause care. Vira Health has…Sep 10, 2021Sep 10, 2021
Julia HawkinsinLatitude NotesOur investment in YulifeWe’re very proud to continue to back YuLife — this time from our Latitude fund — as they raise $70m at Series B, led by Target GlobalJul 14, 2021Jul 14, 2021